ERIC CARELOCK: Open Payments
NPI 1023536646 · HAZLEHURST, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 14 payments from 9 companies in 2025. Trend: 2023 $179 · 2024 $210 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| Novo Nordisk Inc | 2 | $32 |
| Exact Sciences Corporation | 2 | $32 |
| Corcept Therapeutics | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: CAPLYTA, The Cologuard Plus Collection Kit, Korlym, AIRSUPRA, VRAYLAR, ZEPBOUND, ELIQUIS, Wegovy.
Industry payments across GA — which companies pay providers there.
